ID   HXO-Rb44
AC   CVCL_D542
SY   HXO-RB44
DR   ChEMBL-Cells; CHEMBL3307832
DR   ChEMBL-Targets; CHEMBL613981
DR   PubChem_Cell_line; CVCL_D542
DR   Wikidata; Q54897027
RX   PubMed=8575599;
RX   PubMed=22553703;
CC   Population: Chinese.
CC   Doubling time: 44 hours (PubMed=8575599).
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
RX   PubMed=8575599;
RA   Xu, He-Ping
RA   Wang, Cheng-Ye
RA   Zhu, He-Cheng
RA   Liu, Shuang-Zhen
RA   Xu, Xue-Liang
RA   Jiang, You-Qin
RT   "Characteristics of an established retinoblastoma cell line HXO-Rb44.";
RL   Yan Ke Xue Bao 11:16-21(1995).
//
RX   PubMed=22553703; DOI=10.3980/j.issn.2222-3959.2011.05.01; PMCID=PMC3340729;
RA   She, Jun-Jun
RA   Zhang, Peng-Ge
RA   Che, Xiang-Ming
RA   Wang, Xuan
RA   Wang, Zi-Ming
RT   "Side population cells from HXO-Rb44 retinoblastoma cell line have
RT   cancer-initiating property.";
RL   Int. J. Ophthalmol. 4:461-465(2011).
//